Dr. Mohammad Reza Mizani, MD

Dr. Mizani practices at Total Vascular Care in San Antonio, Texas.

Dr. Mizani's NPI, 1497757660, was assigned on June 1, 2005. Dr. Mizani graduated from INTEC Santo Domingo SOM in 1996. Dr. Mizani's Texas license number on file is L2477.

Dr. Mizani's primary practice is Total Vascular Care, at 215 N San Saba, Suite 201, San Antonio, TX 78207. The practice phone is (210) 212-8622.

Dr. Mizani's primary practice is Total Vascular Care in San Antonio, Texas. The medical group on file is South Texas Renal Care Group. Dmand AI also links Dr. Mizani to 2 more dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mizani practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Mizani's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Mizani is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Mizani's licenses on file in 3 states: Texas, California and Maryland.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and gout among the conditions Dr. Mizani treats.

CMS data shows 615 Medicare services from Dr. Mizani across 5 procedure codes in 2024, for 153 Medicare patients. Medicare paid $59,621 for them. Every service was in an office.

CMS counts 153 Medicare patients who saw Dr. Mizani in 2024. The largest group is 75 to 84, with 58 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 22% are also on Medicaid. Their average risk score is 3.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mizani's median patient age at 69, with 48% women.

In 2024, Dr. Mizani wrote 3,678 Medicare Part D claims for 399 patients. 69% of them were for generic drugs. CMS names the drug for 3,160 of them, across 70 drugs with 11 or more claims each, at $1,174,282 in total drug cost. In 2023, CMS named 3,115 claims across 68 drugs.

Dr. Mizani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mizani as offering telehealth.

Dmand AI links 2 papers to Dr. Mizani. Dr. Mizani's most frequent co-authors are Charles Raymond Nolan, MD and Wajeh Y. Qunibi, MD.

Dmand AI links Dr. Mizani to 1 clinical trial. Conditions studied include Hyponatremia and Edema.

CMS Open Payments shows 1,143 general payments to Dr. Mizani from 60 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Amgen Inc. paid the most, $2,391.

Dmand AI lists 2 awards for Dr. Mizani, most recently CMS Stage 1 EHR in 2012.

Dr. Mizani graduated from INTEC Santo Domingo SOM in 1996. Dr. Mizani is a member of ASN.

Dr. Mizani is in network with 22 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.